rss
Ann Rheum Dis 2006;65:1518-1520 doi:10.1136/ard.2005.044834
  • Concise report

Definition of disease duration in ankylosing spondylitis: reassessing the concept

  1. J C Davis1,
  2. M Dougados2,
  3. J Braun3,
  4. J Sieper4,
  5. D van der Heijde5,
  6. S van der Linden5
  1. 1Division of Rheumatology, University of California San Francisco, San Francisco, California, USA
  2. 2Rheumatology B Department, Hospital Cochin, University of Paris, Paris, France
  3. 3Rheumatology Medical Center Ruhrgebiet, Herne, Germany
  4. 4Department of Medicine I, Charite-Campus Benjamin Franklin, Berlin, Germany
  5. 5Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
  1. Correspondence to:
    S van der Linden
    Department of Internal Medicine, Division of Rheumatology, University of Maastricht, PO Box 5800, NL-6202-AZ Maastricht, The Netherlands; Sli{at}sint.azm.nl
  • Accepted 31 January 2006
  • Published Online First 7 February 2006

Abstract

The concept and definition of disease duration in patients with ankylosing spondylitis is ambiguous, and often many years pass between the onset of symptoms and diagnosis. Members of the Assessment in Ankylosing Spondylitis (ASAS) International Working Group by consensus recently recommended identifying specific components of the medical history to better define and document the concept of disease duration. These include (1) the time of onset of the first symptoms of axial manifestations (including inflammatory back pain); (2) the time of onset of the first symptoms of each individual manifestation, which may be an extra-axial sign or symptom of ankylosing spondylitis, such as peripheral arthritis and enthesitis; (3) the time of onset of associated diseases belonging to the spondyloarthritides, in particular acute anterior uveitis, inflammatory bowel disease and psoriasis; and (4) the time since actual diagnosis by a healthcare provider. Such uniformity in data collection will ensure comparability across studies and facilitate future research.

Footnotes

  • Competing interests: None declared.

  • Published Online First 7 February 2006

Responses to this article

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.